Healthcare Alert: DME Supplier CMS Payment Suspension Terminated
June 14, 2024
In a rare move, the Centers for Medicare & Medicaid Services (“CMS”) terminated the payment suspension (the “Suspension”) it previously imposed on a durable medical equipment (“DME”) supplier and agreed to release withheld funds to that provider as a result of Mandelbaum Barrett’s healthcare team’s appeal to CMS.
Mandelbaum Barrett PC has ranked in three practice groups for Chambers USA
June 12, 2024
Success in major deals hinges on collaboration, organization, and teamwork, demonstrating that it truly takes a village to achieve excellence. Our team here at Mandelbaum Barrett PC team embodied these qualities in 2023. Congratulations to our 3 departments who received ranking from Chambers USA: Construction (Band 3), Banking & Finance (Band 3) & Real Estate […]
Brent Pohlman Deciphers the FTC’s New Rule on Non-Compete Clauses in Dental Products Report
June 3, 2024
The FTC’s ban on non-compete clauses has sparked significant discussion in the healthcare industry. Brent Pohlman from Mandelbaum Barrett PC highlights this regulatory shift, rooted in the Biden administration’s focus on non-competition agreements. This change presents both opportunities and challenges for dental associates, emphasizing the need for adaptability and nuanced legal strategies.
New Jersey’s Affordable Housing Projects: Tax Exemptions and Guidelines
May 29, 2024
The introduction of tax exemptions for affordable housing projects in New Jersey signifies a significant stride towards addressing the state’s housing affordability challenges. By providing financial relief to stakeholders involved in these initiatives, New Jersey reaffirms its commitment to promoting equitable access to housing for all its residents, irrespective of income levels. It’s imperative for stakeholders to leverage these exemptions effectively to maximize the positive impact on affordable housing development across the state.
NJBIZ Insight: Joshua Bauchner’s Analysis of Highland Park’s Cannabis Legal Battle
May 20, 2024
Joshua Bauchner analyzes the legal intricacies of Highland Park’s cannabis battle. Bauchner underscores the court’s rejection of federal preemption claims and the uphill battle facing opponents. He emphasizes the inevitability of cannabis legalization in New Jersey despite challenges, offering insights into the legal landscape and the industry’s future.
Deal Alert: Environmental Law Practice Group Advises on $212 Million Acquisition of Four Liquid Energy Terminals
May 16, 2024
Our Environmental Law Practice Group acted as local New Jersey environmental co-counsel to Global Partners LP (“Global”) in its acquisition of four liquid energy terminals from Gulf Oil Limited Partnership (“Gulf Oil”) in April of 2024. The terminals are strategically located in Chelsea, MA, New Haven, CT, Linden, NJ and Woodbury, NJ. Our Environmental Law […]
Exploring the FTC’s Noncompete Ban: Insights from Brent R. Pohlman Featured on Dentistry IQ
May 8, 2024
Curious about the FTC’s recent noncompete ban and its impact on dental practices? Explore the latest developments impacting dental practice employment agreements with insights from Brent R. Pohlman, a Partner in Mandelbaum Barrett PC’s Labor and Employment Practice Group. Understand the implications of the FTC’s recent noncompete ban and how it may reshape your practice’s […]
Mohamed Nabulsi Contributes to Recent Part B News Article Discussing the FTC’s Noncompete Ban as it Applies to Physicians
May 8, 2024
Mohamed Nabulsi, Esq., Chair of the Healthcare Practice Group at Mandelbaum Barrett PC, shared insights in a recent article in Part B News regarding the FTC’s proposed labor-market rule, which could significantly curtail noncompete agreements for physicians if enacted. Nabulsi suggests that this rule might disrupt traditional labor markets, empowering many employees as “free agents” […]
Joshua Bauchner quoted on NJBiz Article: Marijuana reclassification could clear hurdles for NJ businesses
May 6, 2024
In response to the DEA’s recommendation to reschedule marijuana, Joshua Bauchner, emphasized the need for broader reform. Bauchner stated, “While it’s an important step forward in recognizing the long-established medicinal value of cannabis, the ultimate goal is not rescheduling, it’s descheduling.” This underscores the ongoing dialogue surrounding cannabis legislation and the varied viewpoints within the legal community, reflecting the complexities involved in reshaping cannabis policy.